38112003: un (valeur de l'attribut)

SNOMED CT Concept\valeur de l'attribut\nombre\un

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	est un(e) (attribut)	modificateur adjectival général	false	Inferred relationship	Some
un	est un(e) (attribut)	nombre	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Benztropine mesylate 1 mg oral tablet	Has presentation strength numerator value (attribute)	False	un	Inferred relationship	Some	1
Benztropine mesylate 1 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Montelukast sodium 4 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Methyltestosterone 10 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Nitrofurantoin, macrocrystal 25 mg/1 each oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Nitrofurantoin, macrocrystal 50 mg/1 each oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Nitrofurantoin, macrocrystal 100 mg/1 each oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Bupropion hydrochloride 75 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cefuroxime axetil 250 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cefuroxime axetil 500 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cefuroxime axetil 125 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Chlorothiazide 500 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ondansetron hydrochloride 24 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Alosetron hydrochloride 1 mg oral tablet	Has presentation strength numerator value (attribute)	False	un	Inferred relationship	Some	1
Alosetron hydrochloride 1 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cefuroxime axetil 300 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cefuroxime axetil 601.44 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Homatropine methylbromide 5 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Homatropine methylbromide 10 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Acetohydroxamic acid 250 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Calcium acetate 667 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Acetohexamide 250 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Candesartan cilexetil 32 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely methoxsalen 10 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Niacin 500 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Albendazole 200 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely oxazepam 15 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely oxazepam 10 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Oxazepam 30 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Abacavir 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Abacavir 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Abacavir 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Aspirin 325 mg and carisoprodol 200 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 325 mg and carisoprodol 200 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 325 mg and meprobamate 200 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 325 mg and meprobamate 200 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 325 mg and methocarbamol 400 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 325 mg and methocarbamol 400 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Atenolol 100 mg and chlorthalidone 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Atenolol 100 mg and chlorthalidone 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Atenolol 50 mg and chlorthalidone 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Atenolol 50 mg and chlorthalidone 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet	Has presentation strength numerator value (attribute)	False	un	Inferred relationship	Some	2
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Bisoprolol 5 mg and hydrochlorothiazide 6.25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Bisoprolol 5 mg and hydrochlorothiazide 6.25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2

Start Previous Page 121 of 217 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
615211000077111	un (valeur de l'attribut)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
771016011	One (qualifier value)	en	Fully specified name	Inactive	Only initial character case insensitive (core metadata concept)	SNOMED CT core